Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
Status unconfirmed · Phase 3
Conditions studied: Macular Degeneration
In brief
AMD is a progressive disease of the retina which is nourished by a network of tiny blood vessels. There is evidence to suggest that the flow of nutrients to the retina is impaired in patients with AMD. Rheopheresis blood filtration uses blood filters that deplete excesses of large proteins, fats and other substances from the blood, improving blood flow to the macula, potentially improving vision.
Key facts
- Study ID
- NCT00078221
- Run by
- OccuLogix
- People needed
- 180
- Starts
- 1999-08-01
- Expected to finish
- 2005-12-01
- Last updated by the study team
- 2008-05-09
Who can join
Age: 50 and older, up to 85. Sex: any. Healthy volunteers: accepted.
Where it is running
- Retina Vitreous Associates — Beverly Hills, California, United States
- Aran Eye Associates — Coral Gables, Florida, United States
- Retina Health Care — Fort Myers, Florida, United States
- UIC Eye Center — Chicago, Illinois, United States
- Macula Care — New York, New York, United States
- Carolina Eye Associates — Southern Pines, North Carolina, United States
- Associated Retinal Consultants — Bala-Cynwyd, Pennsylvania, United States
- W. Bradley Kates, MD — Oakville, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.